Masi Gabriele, Perugi Giulio, Toni Cristina, Millepiedi Stefania, Mucci Maria, Bertini Nicoletta, Akiskal Hagop S
IRCCS Stella Maris, Scientific Institute of Child Neurology and Psychiatry, Calambrone (Pisa), Italy.
J Child Adolesc Psychopharmacol. 2004 Fall;14(3):395-404. doi: 10.1089/cap.2004.14.395.
Even though juvenile bipolar disorder (BD) is reported to be more treatment-resistant than adult BD, predictors of nonresponse are not well studied. The aim of this study was to address this issue in a naturalistic sample of bipolar children and adolescents with manic or mixed episodes treated under the condition of routine clinical practice. This study was comprised of 40 patients (19 females and 21 males; mean age, 14.2 years; SD = 3.3; range, 7-18) with a Diagnostic and Statistical Manual of Mental Disorders-fourth edition (DSM-IV) diagnosis of manic (n = 23) or mixed episodes (n = 17). The clinical characteristics of 20 patients considered to be treatment responders, according to the Clinical Global Impression-Improvement (CGI-I) scores, were compared to those of the 20 nonresponders. The effect of predictors on the probability of treatment nonresponse was analyzed using the multiple stepwise logistic regression, backward procedure. Demographic variables (mean age, gender ratio, socioeconomic status), as well as the inpatients-outpatients ratio (75% versus 65%), duration of the follow-up (10.5 +/- 2.5 months versus 9.6 +/- 3.2 months), index episode (manic versus mixed), and rates of pharmacologic hypomania did not differentiate the 2 groups. According to stepwise logistic regression, predictors of nonresponse were the presence of comorbidity with conduct disorder (odd ratio, 3.36; 95% CI, 2.20-4.52), attention deficit hyperactivity disorder (ADHD) (odd ratio, 2.30; CI, 1.24-3.26), and the baseline CGI Severity score (odd ratio, 2.31; CI, 1.33-3.29). It is relevant to point out that patient age at the onset of BD, and at the first visit, and comorbid anxiety disorders did not influence treatment response. Follow-up studies with a larger sample size with BD and/or externalizing disorders appropriately managed with different treatment options and/or combinations are warranted.
尽管据报道青少年双相情感障碍(BD)比成人双相情感障碍更具治疗抵抗性,但对无反应的预测因素尚未进行充分研究。本研究的目的是在常规临床实践条件下治疗的有躁狂或混合发作的双相情感障碍儿童和青少年的自然样本中解决这一问题。本研究包括40例患者(19名女性和21名男性;平均年龄14.2岁;标准差=3.3;范围7 - 18岁),根据《精神障碍诊断与统计手册》第四版(DSM - IV)诊断为躁狂发作(n = 23)或混合发作(n = 17)。根据临床总体印象改善(CGI - I)评分,将20例被认为是治疗反应者的临床特征与20例无反应者的特征进行比较。使用多步逐步逻辑回归、向后法分析预测因素对治疗无反应概率的影响。人口统计学变量(平均年龄、性别比例、社会经济地位),以及住院患者与门诊患者比例(75%对65%)、随访时间(10.5±2.5个月对9.6±3.2个月)、索引发作类型(躁狂发作与混合发作)和药物性轻躁狂发生率并未区分这两组。根据逐步逻辑回归,无反应的预测因素是存在品行障碍共病(比值比,3.36;95%可信区间,2.20 - 4.52)、注意缺陷多动障碍(ADHD)(比值比,2.30;可信区间,1.24 - 3.26)以及基线CGI严重程度评分(比值比,2.31;可信区间,1.33 - 3.29)。需要指出的是,双相情感障碍发病时和首次就诊时的患者年龄以及共病焦虑障碍并未影响治疗反应。有必要进行更大样本量的随访研究,对双相情感障碍和/或外化性障碍采用不同治疗选择和/或联合治疗进行适当管理。